Thermo Fisher Scientific Inc.
TMO
$590.83
-$2.42-0.41%
NYSE
| 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/31/2024 | 09/28/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.06% | 7.30% | -17.65% | 12.27% | 5.37% |
| Total Depreciation and Amortization | -0.74% | -4.11% | -5.62% | -0.40% | -3.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 133.33% | -162.50% | -153.78% | 148.77% | -61.59% |
| Change in Net Operating Assets | 85.67% | 49.05% | -339.90% | 1,880.00% | 113.89% |
| Cash from Operations | 60.04% | 93.50% | -78.02% | 51.89% | 10.51% |
| Capital Expenditure | -37.41% | 18.78% | 24.58% | -76.47% | 9.63% |
| Sale of Property, Plant, and Equipment | 300.00% | -91.67% | -29.41% | -15.00% | 25.00% |
| Cash Acquisitions | -- | -- | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6,180.00% | 102.82% | -136.65% | 348.97% | -706.25% |
| Cash from Investing | -1,331.60% | 45.35% | -2,735.00% | 100.56% | -1,314.23% |
| Total Debt Issued | -- | -100.00% | -- | -- | 100.00% |
| Total Debt Repaid | 24.14% | 6.09% | 66.48% | -125.84% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | -100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.62% | -8.72% | 0.00% | 0.67% | -0.67% |
| Other Financing Activities | 90.48% | -193.33% | 364.71% | -125.37% | 91.43% |
| Cash from Financing | 36.23% | -871.57% | 97.22% | -208.07% | -934.78% |
| Foreign Exchange rate Adjustments | -124.12% | 740.54% | 113.55% | -256.00% | 1,266.67% |
| Miscellaneous Cash Flow Adjustments | -- | -100.00% | 200.00% | -- | -100.00% |
| Net Change in Cash | -701.39% | 226.52% | 120.95% | 74.04% | -253.80% |